ARA-290 research peptide vial

Other research compounds

ARA-290

Explore ARA-290 (Cibinetide) research peptide online, documented. Explore its EPOR/CD131 signaling mechanism and tissue-protection research.

Catalogue record
OP-994
Intended use
Research use only
Independent COA on this site
Not available

This corporate catalogue does not take orders, display prices or provide dosage instructions.

Research record

Overview

Compound name: ARA-290

Alternative name: Cibinetide

Compound classification: Synthetic erythropoietin-derived peptide

Brief factual description:

ARA-290 (Cibinetide) is an 11–amino acid synthetic peptide derived from the tissue-protective domain of erythropoietin (EPO). It selectively activates the EPOR/CD131 heteroreceptor complex involved in anti-inflammatory and cytoprotective signaling, while avoiding stimulation of erythropoiesis.

Mechanism of Action

Primary biological targets: EPOR/CD131 heteroreceptor complex

Affected systems: Nervous, immune, metabolic

Core mechanisms:

Activation of tissue-protective EPO receptor pathway

No activation of erythropoietic EPOR homodimers

Downstream effects:

Suppression of pro-inflammatory cytokines

Reduction of oxidative stress

Promotion of nerve repair and cellular survival pathways

Frequently asked questions

What this record can—and cannot—confirm

Is ARA-290 approved for human use?

ARA-290 is supplied strictly for in-vitro laboratory and research use only, not for human consumption or therapeutic use. Regulatory treatment varies by jurisdiction.

How is the purity of ARA-290 verified?

No independent report for this specific product was available in the public migration source. Request batch-specific documentation from the authorised reseller before relying on a purity claim.

Where can I buy ARA-290?

Through an OnlinePeptides authorized reseller. Verify any reseller at onlinepeptides.com/verify-reseller/ before purchasing.